JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 3, 2008; DOI: 10.1124/jpet.108.137919


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.108.137919v1
326/3/871    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Morrey, C.
Right arrow Articles by Levi, R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morrey, C.
Right arrow Articles by Levi, R.


Received for publication February 11, 2008.
Revised May 29, 2008.
Accepted for publication June 2, 2008.

Cardioprotective Effect of Histamine H3-Receptor Activation: Pivotal Role of G{beta}{gamma}-Dependent Inhibition of Voltage-Operated Ca2+ Channels

Christopher Morrey 1, Rima Estephan 1, Geoffrey W. Abbott 1, Roberto Levi 1*

1 Weill Cornell Medical College

* Address correspondence to: E-mail: rlevi{at}med.cornell.edu

Abstract

We previously showed that activation of Gi/o-coupled histamine H3-receptors (H3R) is cardioprotective since it attenuates excessive norepinephrine release from cardiac sympathetic nerves. This action is characterized by a marked decrease in intraneuronal Ca2+ ([Ca2+]i), as G{alpha}i impairs the adenylyl cyclase-cAMP-PKA pathway, and this decreases Ca2+ influx via voltage-operated Ca2+ channels (VOCC). Yet, the Gi/o-derived {beta}{gamma} dimer could directly inhibit VOCC, and the subsequent reduction in Ca2+ influx would be responsible for the H3R-mediated attenuation of transmitter exocytosis. Here, we tested this hypothesis in nerve-growth factor-differentiated rat pheochromocytoma cells (PC12) stably transfected with H3R (PC12-H3) and with the G{beta}{gamma} scavenger {beta}-ARK1-(495-689)-polypeptide (PC12-H3/{beta}-ARK1). Thus, we evaluated the effects of H3R activation directly on: 1) Ca2+ current (ICa) using the whole-cell patch-clamp technique, and 2) K+-induced exocytosis of endogenous dopamine. H3R activation attenuated both peak ICa and dopamine exocytosis in PC12-H3, but not in PC12-H3/{beta}-ARK1 cells. Moreover, a membrane permeable phosducin-like G{beta}{gamma} scavenger also prevented the anti-exocytotic effect of H3R activation. In contrast, the H3R-induced attenuation of cAMP accumulation and dopamine exocytosis in response to forskolin were the same in both PC12-H3 and PC12-H3/{beta}-ARK1 cells. Our findings reveal that while G{alpha}i participates in the H3-mediated anti-exocytotic effect when the adenylyl cyclase-cAMP-PKA pathway is stimulated, a direct G{beta}{gamma}-induced inhibition of VOCC, resulting in an attenuation of ICa plays a pivotal role in the H3R-mediated decrease in [Ca2+]i and associated cardioprotective anti-exocytotic effects. The discovery of this H3R signaling step may offer new therapeutic approaches to cardiovascular diseases characterized by hyperadrenergic activity.


Key words: Gbetagamma dimer, cardiac sympathetic nerve endings, cardioprotection, histamine H3 receptors, norepinephrine exocytosis, voltage-operated calcium channels





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.